SecBot SecBot
S-3 ·Filed Nov 13, 2026

SNOA

Sonoma Pharmaceuticals, Inc.
BEARISH
Impact 5/10
Horizonweeks Processed3d 8h ago SEC0001683168-26-008707
Shelf registration (potential dilution)
Actionable Insight ▼ Bearish

Monitor for prospectus supplements that would indicate actual takedowns under the shelf. The company's cash burn ($1.4M operating cash outflow in H1 FY2027) and history of frequent offerings suggest further capital raises are likely. Any offering would be highly dilutive given the shelf size relative to market cap.

DirectionBearish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Sonoma Pharmaceuticals filed a new S-3 shelf registration to replace its expiring prior shelf, registering up to $46.65 million in securities (common stock, preferred stock, debt securities, warrants, units). The filing carries forward $46.65 million of unsold securities from the prior shelf with no additional filing fee. The company has a market cap of $6M and a public float of $5.6M, and the shelf is subject to the one-third public float limitation under General Instruction I.B.6. The company's latest 10-Q shows revenue growth (Q2 FY2027 revenue $7.2M vs $5.6M YoY) but a net loss of $66K for the quarter and $396K for the six months, with $4.6M cash and $6.6M stockholders' equity. This is a routine shelf replacement filing with no immediate offering, but the potential for significant dilution relative to the company's small market cap is a key risk.

Key Financial Metrics

Offering Size
$46.6M

Key Facts

  • S-3 shelf registration for up to $46,650,000 of securities, replacing expiring prior shelf (File No. 333-275311)
  • Carries forward $46,650,000 of unsold securities from prior shelf; no additional filing fee due
  • Market cap is $6M; public float is $5.6M; shelf is subject to one-third public float limitation under General Instruction I.B.6
  • Company has 5 offering/registration filings in the last 24 months, including this one
  • Q2 FY2027 (Sep 2026) revenue $7.2M, up 28% YoY from $5.6M; net loss $66K vs $534K loss YoY
  • Cash and cash equivalents $4.6M as of Sep 30, 2026; stockholders' equity $6.6M
  • 5,057,755 shares outstanding as of Sep 30, 2026; 5,061,593 as of Nov 10, 2026

Financial Impact

Shelf capacity of $46.65M is approximately 7.8x the company's $6M market cap, representing extreme potential dilution

dilutionshare countmarket cap

Risk Factors

  • Potential for highly dilutive equity offerings given shelf size ($46.65M) vs market cap ($6M)
  • Frequent capital raises (5 offerings in 24 months) indicate ongoing need for external financing
  • Company has net loss and negative operating cash flow, suggesting reliance on equity financing
  • One-third public float limitation may constrain ability to sell large blocks in primary offerings

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0001683168-26-008707
Document: sonoma_s3.htm0001683168-26-008707
Document: sonoma_ex107secex.htm0001683168-26-008707
Document: sonoma_ex0501.htm0001683168-26-008707
Document: sonoma_ex2301.htm0001683168-26-008707
Document: 0001683168-26-008707-index-headers.html0001683168-26-008707
Document: 0001683168-26-008707-index.html0001683168-26-008707
Document: 0001683168-26-008707.txt0001683168-26-008707

Track record

7 reports on SNOA

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +6.31% at T+1 after the Apr 27, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 13, 20263d ago S-3 Bearish 5/10 Viewing Entry $1.20 Now $0.8800 +26.67% settles Nov 17
  2. Oct 6, 20265w ago 8-K Neutral 3/10 Entry $1.22 to $1.16 Now $0.8800 −27.87% ▼ −4.92% −4.49% vs SPY
  3. Jun 18, 202621w ago 8-K Bearish 6/10 Entry $1.16 to $1.14 Now $0.8800 +24.14% ▲ +1.72% +0.27% vs SPY
  4. Jun 18, 202621w ago 424B5 Bearish 6/10 Entry $1.16 to $1.14 Now $0.8800 +24.14% ▲ +1.72% +0.27% vs SPY
  5. Apr 27, 202629w ago 424B4 Bearish 6/10 Entry $1.11 to $1.04 Now $0.8800 +20.72% ▲ +6.31% +5.82% vs SPY
  6. Apr 17, 202630w ago S-1 Neutral 5/10 Entry $2.65 to $2.25 Now $0.8800 −66.79% ▼ −15.09% −14.44% vs SPY
  7. Apr 9, 202631w ago 8-K Neutral 4/10 Entry $2.41 to $2.28 Now $0.8800 −63.49% ▼ −5.39% −5.33% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens in 8h 30m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026